Magainin Pharm (MAGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Magainin Pharm (MAGN)

MAGN 8.890

+2.2%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cody Goebel who wrote (67)	8/6/1997 9:13:00 PM
From: Shlepper	of 233

Hi Cody, I've been with Magainin for 5 years and I don't worry about these moves. The stock went up on high volume and down on low volume - that's a good sign. What's important is that (1) the Cytolex is in the NDA process - though I'm not sure where at this point, and (2) the compounds from the squalamine are very promising. I expect that the stock price should move upwards as the final approval nears. My guess is that the price will be between 18 and 25 at this point. The pipeline isn't real strong right now, but with the funding from the approved drug, I expect huge activity down the road with some blockbuster drugs. I've waited 5 years, and it'll probably be another 5 years before the big drug money flows. I'll probably buy more after approval since the future of the company will be more certain. If something goes wrong in the approval, then all bets are off for the short term, although the long term may still be great. Hang in there - I waited a long time for Medimmune and it has just hit paydirt. Most of my money and hopes, though, have been with Magainin. Good Luck, Shep

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next